Evaluation of psychological distress is essential for patients with locally advanced breast cancer prior to neoadjuvant chemotherapy: baseline findings from cohort study.

Journal: BMC women's health

Volume: 23

Issue: 1

Year of Publication: 2023

Affiliated Institutions:  Laboratory of Epidemiology and Research in Health Sciences, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdallah University, Fez, Morocco. majid.omari@usmba.ac.ma. Department of Medical Oncology, Hassan II University Hospital, Fez, Morocco. Laboratory of Epidemiology and Research in Health Sciences, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdallah University, Fez, Morocco. Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box , Riyadh, , Saudi Arabia. Higher Institute of Nursing Professions and Health Techniques, Fez, Morocco. Laboratory of Natural Substances, Pharmacology, Environment, Modeling, Health & Quality of Life, Faculty of Sciences Dhar El Mahraz, Sidi Mohamed Ben Abdellah University, Fez, Morocco. Laboratory of Pedagogical and Didactic Engineering of Sciences and Mathematics, Regional Center of Education and Training (CRME F) of Fez, Fez, Morocco. Toxicology Centre, University of Saskatchewan, Saskatoon, SK, SN B, Canada.

Abstract summary 

patients with locally advanced breast cancer (LABC) are often treated by neoadjuvant chemotherapy (NACT). This study aims to determine the prevalence of psychological distress and their sociodemographic and clinical factors in patients recently diagnosed with LABC and before NACT.A total of 209 LABC patients without metastatic localization were recruited between 2021 and 2022 in the oncology hospital at Fez. A structured questionnaire and the Hospital Anxiety and Depression Scale were used. A descriptive analysis and linear model were performed.a mean age of participants was 47.43 ± 9.45 years. The prevalence of depression, anxiety and psychological distress among participants was 59.62% (95% CI: 52.61-33.34), 47.85% (95% CI: 40.91-54.85), and 65.07 (95% CI: 58.19-71.52) respectively. Depression was associated to age (< 50 years) (AOR = 2.19; 95% CI = 1.13-4.23) and health insurance (AOR = 3.64; 95% CI: 1.18-11.26). Anxiety was associated to age (< 50) (AOR = 2.21; 95% CI: 1.18-4.13) and right breast cancer (AOA = 2.01; 95% CI: 1.11-3.65). Psychological distress was associated to chronic illness (AOR = 2.78; 95% CI: 1.32-5.85) and lymph node status (AOR = 2.39; 95% CI: 1.26-4.57).Based on the high prevalence of depression and anxiety it appears opportune to treat psychological distress among LABC patient candidates for NACT. Each psychological intervention should take into account sociodemographic and clinical factors found associated in our study. Psychological therapeutic interventions are crucial for LABC patients as early as the time of diagnosis and through subsequent steps in NACT to improve their overall mental health.

Authors & Co-authors:  Omari Majid M Amaadour Lamiae L Zarrouq Btissame B Al-Sheikh Yazeed A YA El Asri Achraf A Kriya Salima S Nadi Sara S Benbrahim Zineb Z Mellas Nawfel N Rhazi Karima El KE Ragala Mohammed El Amine MEA Hilaly Jaouad El JE Giesy John P JP Aboul-Soud Mourad A M MAM Halim Karima K

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Sung H, Rl JF. S, M L, I S, A J, Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians [Internet]. mai 2021 [cité 22 nov 2022];71(3). Disponible sur: https://pubmed.ncbi.nlm.nih.gov/33538338/
Authors :  15
Identifiers
Doi : 445
SSN : 1472-6874
Study Population
Male,Female
Mesh Terms
Humans
Other Terms
Anxiety;Clinical factors;Depression;Locally advanced breast cancer;Neoadjuvant chemotherapy;Psychological distress;Sociodemographic factors
Study Design
Cohort Study,Descriptive Study
Study Approach
Country of Study
Publication Country
England